Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jason A Wilken
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Related publications
Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy
Oncology Letters
Cancer Research
Oncology
Epidermal Growth Factor Receptor-Targeted Photosensitizer Selectively Inhibits EGFR Signaling and Induces Targeted Phototoxicity in Ovarian Cancer Cells
Cancer Letters
Cancer Research
Oncology
Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Fibroblast Growth Factor 2 Lethally Sensitizes Cancer Cells to Stress-Targeted Therapeutic Inhibitors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway
Cancer Management and Research
Oncology
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Cancer Research
Cancer Research
Oncology
Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro
Oncology Reports
Medicine
Cancer Research
Oncology
Targeting the High Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
Cancer Research
Cancer Research
Oncology
Cancer Targeted Therapeutics: From Molecules to Drug Delivery Vehicles
Journal of Controlled Release
Pharmaceutical Science
